首页|伏诺拉生联合阿莫西林治疗幽门螺杆菌感染的疗效及安全性分析

伏诺拉生联合阿莫西林治疗幽门螺杆菌感染的疗效及安全性分析

扫码查看
目的 分析伏诺拉生+阿莫西林治疗幽门螺杆菌(Hp)感染的效果与安全性。方法 选择110 例Hp感染患者为研究对象,采用随机数字表法分为观察组(n=55)与对照组(n=55)。对照组采用基于质子泵抑制剂(PPI)的四联疗法治疗,观察组采用伏诺拉生+阿莫西林二联疗法治疗。比较两组研究完成情况、Hp根除率、不良反应发生率。结果 两组研究完成率比较无统计学差异(P>0。05)。意向性治疗(ITT)分析结果显示,观察组与对照组Hp根除率分别为87。3%与80。0%,比较无统计学差异(P>0。05);符合方案集(PP)分析结果显示,观察组与对照组Hp根除率分别为 92。3%与 88。0%,比较无统计学差异(P>0。05)。观察组 7 例发生不良反应,包括 2 例恶心呕吐、2 例腹痛、7 例腹胀,不良反应发生率为13。5%。对照组 15 例发生不良反应,包括 2 例恶心呕吐、3 例腹痛、1 例腹泻、4 例腹胀、2 例味觉异常、2 例头晕、1 例皮疹,不良反应发生率为 30。0%。观察组不良反应发生率低于对照组(P<0。05)。结论 伏诺拉生+阿莫西林治疗Hp感染的效果与安全性满意。
Analysis of efficacy and safety of the combination of vonoprazan and amoxicillin in the treatment of Helicobacter pylori infection
Objective To analyze the effect and safety of the combination of vonoprazan and amoxicillin in the treatment of Helicobacter pylori(Hp)infection.Methods 110 patients with Hp infection were enrolled and divided into an observation group(n=55)and a control group(n=55)according to random numerical table.The control group received a quadruple therapy based on proton pump inhibitor(PPI),and the observation group received dual therapy of vonoprazan and amoxicillin.The study completion,Hp eradication rate and incidence of adverse reactions were compared between two groups.Results There was no significant difference in study completion rate between the two groups(P>0.05).The results of intention-to-treat(ITT)analysis showed that the Hp eradication rates of the observation group and control group were 87.3%and 80.0%,respectively,with no statistical difference(P>0.05).The per protocol(PP)analysis showed that Hp eradication rates in the observation and control groups were 92.3%and 88.0%,respectively,with no statistical difference(P>0.05).In the observation group,7 cases had adverse reactions,including 2 cases of nausea and vomiting,2 cases of abdominal pain and 7 cases of abdominal distension,the incidence of adverse reactions was 13.5%.In the control group,15 cases had adverse reactions,including 2 cases of nausea and vomiting,3 cases of abdominal pain,1 case of diarrhea,4 cases of abdominal distension,2 cases of abnormal taste,2 cases of dizziness,1 case of rash,the incidence of adverse reactions was 30.0%.The incidence of adverse reactions in the observation group was lower than that in the control group(P<0.05).Conclusion The efficacy and safety of vonoprazan+amoxicillin in the treatment of Hp infection are satisfactory.

Helicobacter pylori infectionVonoprazanAmoxicillinDual therapyProton pump inhibitorsQuadruple therapy

林文博、万清治

展开 >

362261 晋江市第二医院(安海医院)消化内科

362261 晋江市第二医院(安海医院)眼耳鼻咽喉科

幽门螺杆菌感染 伏诺拉生 阿莫西林 二联疗法 质子泵抑制剂 四联疗法

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(22)